Xu-Feng Huang Selected Research

Metabotropic Glutamate 5 Receptor

8/2015	Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.
7/2015	Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.
5/2013	Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xu-Feng Huang Research Topics

Disease

95	Schizophrenia (Dementia Praecox) 05/2024 - 03/2004
61	Obesity 02/2024 - 07/2003
35	Body Weight (Weight, Body) 02/2024 - 04/2005
32	Weight Gain 01/2020 - 08/2006
27	Inflammation (Inflammations) 01/2022 - 01/2011
24	Cognitive Dysfunction 01/2024 - 02/2009
15	Mental Disorders (Mental Disorder) 02/2024 - 03/2004
12	AIDS-Related Complex (ARC) 01/2020 - 06/2002
10	Neuroinflammatory Diseases 12/2023 - 10/2016
8	Hyperphagia (Overeating) 01/2020 - 03/2011
7	Psychotic Disorders (Schizoaffective Disorder) 11/2023 - 11/2014
6	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021 - 03/2009
5	Bipolar Disorder (Manic Depressive Psychosis) 11/2023 - 03/2004
5	Insulin Resistance 05/2018 - 12/2013
5	Glucose Intolerance 05/2018 - 01/2014
5	Necrosis 08/2016 - 01/2011
5	Colonic Neoplasms (Colon Cancer) 06/2011 - 07/2009
4	Neoplasms (Cancer) 07/2022 - 08/2009
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018 - 02/2012
4	Type 2 Diabetes Mellitus (MODY) 04/2017 - 12/2013
4	Weight Loss (Weight Reduction) 09/2014 - 12/2009
3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 04/2018
3	Morbid Obesity 01/2020 - 06/2013
3	Diabetes Mellitus 01/2017 - 02/2012
3	Carcinogenesis 06/2011 - 06/2009
3	Overweight 04/2010 - 10/2009
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2021
2	Hyperthermia 07/2022 - 01/2021
2	Tardive Dyskinesia 12/2021 - 03/2015

Drug/Important Bio-Agent (IBA)

50	Antipsychotic Agents (Antipsychotics)IBA 02/2024 - 06/2008
37	Olanzapine (Zyprexa)FDA Link 02/2024 - 05/2007
23	Proteins (Proteins, Gene)FDA Link 01/2023 - 02/2008
22	Messenger RNA (mRNA)IBA 01/2023 - 06/2002
16	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2022 - 01/2007
13	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 06/2015
13	Insulin (Novolin)FDA Link 01/2021 - 10/2009
13	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2020 - 06/2008
12	Glucose (Dextrose)FDA LinkGeneric 10/2018 - 01/2010
11	LeptinIBA 01/2024 - 06/2002
10	Clozapine (Clozaril)FDA LinkGeneric 05/2024 - 02/2010
9	Aripiprazole (Abilify)FDA Link 01/2018 - 06/2008
9	Neuregulin-1 (Neuregulin 1)IBA 01/2017 - 08/2009
9	bardoxolone methylIBA 08/2016 - 01/2014
8	Neuropeptide YIBA 01/2020 - 07/2003
8	Phencyclidine (Angel Dust)IBA 10/2019 - 02/2009
8	N-Methylaspartate (NMDA)IBA 01/2018 - 02/2009
7	Haloperidol (Haldol)FDA LinkGeneric 12/2021 - 06/2008
7	Cholinergic Agents (Cholinergics)IBA 04/2018 - 03/2004
6	CannabidiolIBA 01/2023 - 08/2010
6	gamma-Aminobutyric Acid (GABA)IBA 12/2019 - 07/2006
6	CannabinoidsIBA 12/2019 - 07/2006
6	Histamine (Histamine Dihydrochloride)FDA Link 11/2017 - 02/2010
6	Interleukin-6 (Interleukin 6)IBA 08/2016 - 06/2009
6	Betahistine (Serc)IBA 04/2016 - 09/2012
5	CytokinesIBA 01/2021 - 01/2015
5	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 09/2020 - 04/2005
5	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2020 - 12/2012
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2019 - 07/2006
5	Glutamic Acid (Glutamate)FDA Link 12/2019 - 07/2006
5	Neurotransmitter Agents (Neurotransmitter)IBA 12/2019 - 07/2005
5	Histamine H3 Receptors (Histamine H3 Receptor)IBA 11/2017 - 02/2010
5	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 04/2005
4	Neuroprotective AgentsIBA 01/2024 - 06/2016
4	GlucansIBA 01/2022 - 07/2011
4	AntioxidantsIBA 11/2020 - 08/2014
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2020 - 07/2005
4	Poly I-CIBA 12/2019 - 11/2016
4	LipidsIBA 01/2017 - 02/2014
4	metabotropic glutamate receptor 2IBA 04/2016 - 05/2011
4	Peptides (Polypeptides)IBA 03/2015 - 10/2009
4	PirenzepineIBA 05/2012 - 03/2004
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2009 - 03/2004
3	NeuropeptidesIBA 02/2024 - 12/2009
3	Ghrelin ReceptorsIBA 02/2024 - 11/2013
3	Serotonin (5 Hydroxytryptamine)IBA 02/2024 - 08/2004
3	EnzymesIBA 01/2022 - 01/2012
3	4-phenylbutyric acid (Buphenyl)FDA Link 08/2021 - 01/2019
3	EndocannabinoidsIBA 12/2019 - 11/2007
3	LipopolysaccharidesIBA 01/2019 - 10/2016
3	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2019 - 01/2007
3	Dizocilpine Maleate (Dizocilpine)IBA 01/2018 - 08/2005
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2018 - 11/2014
3	RimonabantIBA 06/2016 - 11/2007
3	Metabotropic Glutamate 5 ReceptorIBA 08/2015 - 05/2013
3	Therapeutic UsesIBA 01/2015 - 06/2012
3	AMP-Activated Protein KinasesIBA 12/2014 - 04/2014
3	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2014 - 12/2009
3	Hormones (Hormone)IBA 05/2014 - 04/2010
3	GhrelinIBA 05/2014 - 05/2012
3	(1-3)(1-4)- beta-glucanIBA 04/2010 - 10/2009
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2008 - 07/2006
2	dimethyl itaconateIBA 03/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Butyrates (Butyrate)IBA 01/2023 - 01/2023
2	Dietary Fiber FDA Link 11/2021 - 11/2018
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 12/2020 - 01/2018

Therapy/Procedure

12	Therapeutics 07/2022 - 12/2010
4	Oral Administration 01/2020 - 03/2015
3	Drug Therapy (Chemotherapy) 11/2018 - 02/2008
2	Precision Medicine 07/2022 - 01/2021